Meyler's Side Effects of Psychiatric Drugs
- 1st Edition - October 10, 2008
- Imprint: Elsevier Science
- Author: Jeffrey K. Aronson
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 4 - 5 6 3 2 2 - 4
- Hardback ISBN:9 7 8 - 0 - 4 4 4 - 5 3 2 6 6 - 4
- eBook ISBN:9 7 8 - 0 - 0 8 - 0 9 3 2 8 7 - 3
Elsevier now offers a series of derivative works based on the acclaimed Meylers Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefi… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteElsevier now offers a series of derivative works based on the acclaimed Meylers Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing physician or health care clinician. The unwarranted effects of medications used in psychiatry can adversely affect a treatment plan. This book is critical in helping psychiatrists and mental health professionals assess the adverse effects of drugs such as antidepressants, mood stabilizers, hypnosedatives, and antipsychotic drugs.The material is drawn from the 15th edition of the internationally renowned encyclopedia, Meyler’s Side Effects of Drugs, and the latest volumes in the companion series, Side Effects of Drugs Annuals. Drug names have usually been designated by their recommended or proposed International Non-proprietary Names (rINN or pINN); when those are not available, clinical names have been used. In some cases, brand names have been used.This volume is critical for any health professional involved in the administration of psychiatric mediations.
- Surpasses the Physician’s Desk Reference © by including clinical case studies and independent expert analysis
- Complete index of drug names
- Most complete cross referencing of drug-drug interactions available
- Extensive references to primary and secondary literature
- Also includes information on adverse effects in pregnancy
The book is divided into six sections:
- Antidepressants – A general introduction to their adverse effects, followed by monographs on individual drugs and groups of drugs (including lithium)
- Neuroleptic drugs – A general introduction to their adverse effects, followed by monographs on individual drugs
- Hypnosedatives - A general introduction to their adverse effects, followed by monographs on individual drugs
- Drugs of abuse
- Drugs used to treat Alzheimer’s disease
- Psychological and psychiatric adverse effects of non-psychoactive drugs
Psychiatrists, mental health professionals
PrefaceAntidepressantsTricyclic AntidepressantsSelective Serotonin Re-uptake Inhibitors (SSRIS)Monoamine Oxidase InhibitorsOther AntidepressantsLithium Neuroleptic DrugsHypnosedativesBenzodiazepinesNon-benzodiazepine HypnosedativesDrugs of AbuseAmphetaminesCannabinoidsCocaineDexamfetamineDiamorphine (Heroin)DimethyltryptamineGammahydroxybutyrateKhatLysergideMescalineMetamfetamineMethadoneMethylenedioxymetamfetamine (MDMA, Ecstasy)Organic SolventsPhencyclidinePsilocybinDrugs Used in Alzheimer’s Disease 629Psychological and Psychiatric Adverse Effects of Non-psychoactive DrugsIndex of Drug Names
- Edition: 1
- Published: October 10, 2008
- Imprint: Elsevier Science
- No. of pages: 512
- Language: English
- Paperback ISBN: 9780444563224
- Hardback ISBN: 9780444532664
- eBook ISBN: 9780080932873
JA
Jeffrey K. Aronson
Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK’s National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.
Affiliations and expertise
consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust